secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fulcrum Therapeutics, Inc. (FULC)
CIK:        0001680581
Form:       8-K
Filed at:   2026-01-12T23:59:59+00:00
Accession:  0001193125-26-009845
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Fulcrum reports ~$352.3M cash as of Dec 31, 2025; updates presentation for JPM conference
--------------------------------------------------------------------------------

- Preliminary unaudited cash, cash equivalents and marketable securities of $352.3M as of December 31, 2025.
- Updated corporate slide presentation (Exhibit 99.1) issued January 12, 2026, containing business and strategic updates.
- Management to present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026 at 7:30 a.m. PT.
- Presentation will be webcast live on Fulcrum's investor relations website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1680581/000119312526009845/0001193125-26-009845-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1680581/000119312526009845/fulc-20260112.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-009845

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer